Cargando…

Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies

Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc). However, mortality is improving as pathogenesis is being better understood and new therapies emerge. The roles of the inflammasome and NETosis in fibrosis are being elucidated. Epigenetic targets like DNA me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Sakir, Pattanaik, Sarit Sekhar, Rai, Mohit Kumar, Nath, Alok, Agarwal, Vikas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046043/ https://www.ncbi.nlm.nih.gov/pubmed/32185315 http://dx.doi.org/10.31138/mjr.29.3.140

Ejemplares similares

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
por: Castelino, Flavia V, et al.
Publicado: (2010)

Pathogenesis of Systemic Sclerosis
por: Pattanaik, Debendra, et al.
Publicado: (2015)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Tuberculosis remains a leading contributor to morbidity due to serious infections in Indian patients of SLE
por: Chatterjee, Rudrarpan, et al.
Publicado: (2023)

Management of Connective Tissue Disease–related Interstitial Lung Disease
por: Ahmed, Sakir, et al.
Publicado: (2022)

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Cellular interactions in the pathogenesis of interstitial lung diseases
por: Bagnato, Gianluca, et al.
Publicado: (2015)

Focusing on diffuse (interstitial) lung disease: a rapidly evolving field
por: du Bois, Roland M
Publicado: (2002)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

Chitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPD
por: Cho, Soo Jung, et al.
Publicado: (2015)

Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
por: Kim, Yerin, et al.
Publicado: (2023)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Lungs after COVID-19: Evolving Knowledge of Post–COVID-19 Interstitial Lung Disease
por: Aronson, Kerri I., et al.
Publicado: (2021)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Perturbed Glucose Metabolism: Insights into Multiple Sclerosis Pathogenesis
por: Mathur, Deepali, et al.
Publicado: (2014)

Novel insights into dendritic cells in the pathogenesis of systemic sclerosis
por: Carvalheiro, T., et al.
Publicado: (2020)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2020)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2022)

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
por: Boleto, Gonçalo, et al.
Publicado: (2022)

Common variable immunodeficiency (CVID) with granulomatous interstitial lung disease (GLILD) and SARS COVID-19 infection: case report and review of literature
por: Pattanaik, Debendra, et al.
Publicado: (2021)

Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States
por: Fan, Yanni, et al.
Publicado: (2020)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis
por: Zhou, Wan, et al.
Publicado: (2023)

Interstitial Granulomatous Dermatitis with Granuloma Annulare-Like Pattern Following Liposuction
por: Agarwal, Indu, et al.
Publicado: (2017)

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management
por: Kadura, Suha, et al.
Publicado: (2021)

Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management
por: Kumar, Sudhir, et al.
Publicado: (2018)

Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management
por: Chowaniec, Małgorzata, et al.
Publicado: (2018)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Patient and Physician Perspectives on Systemic Sclerosis–Associated Interstitial Lung Disease
por: Cheema, Tariq J, et al.
Publicado: (2020)

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020)

Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer, Aryeh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nhls46hh235i0i2tqkloideve0